# Pilot Study on Evaluating the Geroprotective Effect of Metformin

> **NCT06459310** · PHASE2 · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 130 (estimated)

## Conditions studied

- Metformin
- Aging

## Interventions

- **DRUG:** Metformin Hydrochloride tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06459310
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2026-09-30
- **Final completion:** 2028-07-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06459310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06459310, "Pilot Study on Evaluating the Geroprotective Effect of Metformin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06459310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*